Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1994-09-23
1996-12-03
Jacobson, Dian C.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424 9464, 435212, 435215, 435226, A61K 3849, C12N 948, C12N 972, C12N 964
Patent
active
055805590
ABSTRACT:
Novel single-chain hybrid plasminogen activators having an amino acid sequence composed of at least two subsequences corresponding in amino acid identity and number to subsequences of human t-PA and of human u-PA, and mutants thereof in which at least one of the N-glycosylation sites is modified such that glycosylation cannot take place at these sites exhibit valuable pharmacological properties. The hybrid plasminogen activators are produced by recombinant DNA technology.
REFERENCES:
patent: 4916071 (1990-04-01), Hung et al.
patent: 5204255 (1993-04-01), Tagawa et al.
de Vries et al., "Artificial Exon Shuffling: Construction of Hybrid cDNAs Containing Domains of Tissue-Type Plasminogen Activator (t-PA) and Urokinase (u-PA)", Thrombosis and Haemostasis, 58: Abstract No 1141:314 (1987).
Friezner-Degen et al., "The Human Tissue Plasminogen Activator Gene", J. Biol. Chem. 261 (15):6972-6981 (1986).
Gheysen et al., "Characterization of a Recombinant Fusion Protein of the Finger Domain of Tissue-type Plasminogen Activator with a Truncated Single Chain Urokinase-type Plasminogen Activator", J. Biol. Chem., 262(24): 11779-11784 (1987).
Holmes et al., "Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli", Biotechnology, 3:923-929 (1985).
Ichinose et al., "Localization of the Binding Site of Tissue-Type Plasminogen Activator to Fibrin", J. Clin. Invest., 78:163-169 (1986).
Kagitani et al., "Expression of E. coli of finger-domain lacking tissue-type plasminogen activator with high fibrin affinity", FEBS LETTERS, 189(1): 145-149 (1985).
Lee et al., "Construction and Expression of Hybrid Plasminogen Activators Prepared from Tissue-Plasminogen Activator (t-PA) and Urokinase (u-PA) Genes", Thrombosis and Haemostasis, 58: Abstract No. 1140:313 (1987).
Novokhatny et al., "Domains in Human Plasminogen", J. Mol. Biol., 179:215-232 (1984).
Ny et al., "The structure of the human tissue-type plasminogen activator gene: Correlation of intron and exon structures to functional and structural domains", Proc. Natl. Acad. Sci, USA, 81: 5355-5359 (1984).
Penninca et al., "Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli", Nature, 301: 214-221 (1983).
Pierard et al., "Mutant and Chimeric Recombinant Plasminogen Activators", J. Biol. Chem., 262(24): 11771-11778 (1987).
Riccio et al., "The human urokinase-plasminogen activator gene and its promoter", Nucleic Acids Research, 13(8): 2759-2771 (1985).
Robbins et al., "Covalent molecular weight-92,000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.", Chemical Abstracts, 105: 322 #20872a (1986).
Ryan et al., "Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin", Biochimica et Biophysica. Acta., 830: 187-194 (1985).
Trexler et al., "Residues of Cys-1 and Cys-79 are not Essential for Refolding of Reduced-Denatured Kringle 4 Fragment of Human Plasminogen", Biochimica et Biophysica. Acta., 787: 275-280 (1984).
Vali et al., "The Fibrin-binding Site of Human Plasminogen", J. Biol. Chem., 259: 13690-13694 (1984).
van Zonneveld et al., "Autonomous functions of structural domains on human tissue-type plasminogen activator", Proc. Natl. Acad. Sci, USA, 83: 4670-4674 (1986).
Alkan Sefik
Asselbergs Fredericus A. M.
Chaudhuri Bhabatosh
Heim Jutta
Meyhack Bernd
Ciba-Geigy Corporation
Elmer James Scott
Jacobson Dian C.
LandOfFree
Hybrid plasminogen activator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid plasminogen activator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid plasminogen activator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-783289